TAOX Valuation Metrics
FCF$-6.40M
FCF Growth Rate—
EPS Growth (CAGR)—
WACC10.00%
TAO Synergies Inc
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
TAO Synergies Inc. is the first pure-play public company dedicated to the intersection of cryptocurrency and AI, with a treasury strategy centered on acquiring, staking, and leveraging Bittensor (TAO) tokens. By providing transparent, regulated exposure to decentralized AI, TAO Synergies empowers investors to participate in the next era of technological disruption.
Did you know?
Price sits at 39% of its 52-week range.
Current Price
$5.33
+3.90%Profile
Valuation (TTM)
Market Cap$38.00M
P/E-1.30
EV—
P/B1.80
Shares Out7.13M
P/Sales127.05
Revenue$299061.00
EV/EBITDA—
TAO Synergies Inc (TAOX) Valuation
Fair Value Models
Graham Number, PEG-based, and Earnings-based models
View Fair Value →TAOX Valuation & Fair Value Analysis
TAO Synergies Inc (TAOX) valuation analysis using multiple fair value methodologies. GoodMoat calculates a blended fair value target using discounted cash flow (DCF) analysis, the Graham Number, and earnings-based valuation models.
The price-to-earnings (P/E) ratio is -1.30. Price-to-book ratio is 1.80. Price-to-sales ratio is 127.05. PEG ratio is 0.01.
GoodMoat's valuation models include the Graham Number (based on EPS and book value), an earnings-based model (discounted future EPS), and a PEG-adjusted valuation. The three models are averaged to produce a blended fair value estimate. Use these tools alongside the DCF calculator and reverse DCF to form a comprehensive view of TAO Synergies Inc's intrinsic value.